Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 23,176–23,200 of 27,380 studies, newest first · page 928 of 1096.

April 2006 25

  1. 2006-04-24

    Thyroid hormones, dementia, and atrophy of the medial temporal lobe

    ✓ Peer-reviewed Brain scans and imaging The Journal of clinical endocrinology and metabolism

    Key finding: In our study, TSH was related neither to risk of AD nor with early MRI markers thereof, arguing against an important role of thyroid function in the development of AD. +3 more findings

  2. 2006-04-19

    Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

    ✓ Peer-reviewed Drug development Neurobiology of disease

    Key finding: Recent data have revealed that soluble oligomeric amyloid-beta peptide (Abeta) may be the proximate effectors of neuronal injuries and death in Alzheimer's disease (AD) by unknown mechanisms. +3 more findings

  3. 2006-04-19

    Memantine for dementia

    ✓ Peer-reviewed Cognitive tests and assessment The Cochrane database of systematic reviews

    Key finding: Patients taking memantine were slightly less likely to develop agitation (134/1739, 7.7% versus 175/1873, 9.3% OR 0.78, 95% CI 0.61 to 0.99, P = 0.04).

  4. 2006-04-19

    ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: EGCG seems to accomplish this by modulating amyloid precursor protein (APP) processing, resulting in enhanced cleavage of the alpha-COOH-terminal fragment (alpha-CTF) of APP and corresponding elevation of the NH(2)-terminal APP product, soluble APP-alpha (sAPP-alpha). +3 more findings

  5. 2006-04-18

    Mediterranean diet and risk for Alzheimer's disease

    ✓ Peer-reviewed Prevention and risk Annals of Neurology

    We conclude that higher adherence to the MeDi is associated with a reduction in risk for AD.

  6. 2006-04-18

    The effect of acetyl-L-carnitine administration on persons with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Research in developmental disabilities

    Key finding: Since previous investigations reported improvements in cognition of patients with dementia after acetyl-L-carnitine therapy and since there is an increased risk for persons with Down syndrome to develop Alzheimer disease, this study was designed to investigate the effect of acetyl-L-carnitine administration on neurological, intellectual, and social functions in adults with Down syndrome. +1 more finding

  7. 2006-04-13

    Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

    ✓ Peer-reviewed Lewy body dementia Brain : a journal of neurology

    Key finding: VBM revealed the premotor and supplemental motor cortices to be the main cortical regions associated with AOS, while the anterior peri-sylvian region was associated with non-fluent aphasia.

  8. 2006-04-10

    Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's American journal of human genetics

    Key finding: The present study provides evidence that APP-promoter mutations that significantly increase APP expression levels are associated with AD.

  9. 2006-04-07

    Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice

    ✓ Peer-reviewed Genetics Journal of neuroinflammation

    Key finding: Here we showed that activation of primary astrocytes from TR APOE mice with LPS led to TR APOE-dependent differences in cytokine secretion that were greatest in TR APOE2 and that were associated with differences in NF-kappaB subunit activity. +1 more finding

  10. 2006-04-03

    Measuring change in activities of daily living in nursing home residents with moderate to severe cognitive impairment

    ✓ Peer-reviewed Health systems and care delivery BMC geriatrics

    Key finding: The MDS-ADL Long Form scale detected clinically meaningful change in physical function in a large cohort of long-stay nursing home residents with moderate to severe dementia, supporting its use as a research tool in future studies.

  11. 2006-04-01
  12. 2006-04-01

    Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

    ✓ Peer-reviewed Treatments Lancet (London, England)

    Key finding: 95 patients assigned donepezil and 99 patients assigned placebo completed the study.

  13. 2006-04-01

    Hippocampal and amygdalar volumes in dissociative identity disorder

    ✓ Peer-reviewed Hippocampus size on brain scans The American journal of psychiatry

    Key finding: The findings are consistent with the presence of smaller hippocampal and amygdalar volumes in patients with dissociative identity disorder, compared with healthy subjects. +3 more findings

  14. 2006-04-01

    Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study

    ✓ Peer-reviewed Clinical safety Journal of neurology, neurosurgery, and psychiatry

    Key finding: Measures to prevent the morbidity associated with falls and fractures in bradykinetic rigid syndromes may be best directed at patients with the risk factors identified in this study. +1 more finding

  15. 2006-04-01

    ESPEN Guidelines on Enteral Nutrition: Geriatrics

    ✓ Peer-reviewed Clinical safety Clinical nutrition (Edinburgh, Scotland)

    Key finding: In elderly people at risk of undernutrition ONS improve nutritional status and reduce mortality. +4 more findings

  16. 2006-04-01

    Atypical progressive supranuclear palsy with corticospinal tract degeneration

    ✓ Peer-reviewed Disease mechanisms Journal of neuropathology and experimental neurology

    Key finding: The mean age at onset and illness duration was 71 and 5.7 years, respectively. +4 more findings

  17. 2006-04-01

    Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease

    ✓ Peer-reviewed Risk genes beyond APOE Alzheimer disease and associated disorders

    Key finding: The accumulation of evidence implicating AChE in the pathogenesis of AD raises the question of whether, in addition to their palliative actions, inhibitors of this enzyme are able to act as disease-modifying agents. +3 more findings

  18. 2006-04-01

    Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease

    ✓ Peer-reviewed Mild cognitive impairment Archives of neurology

    Key finding: Interferon-gamma-inducible protein 10 is specifically increased in MCI and seems to decrease with the progression of AD, whereas MCP-1 and IL-8 are up-regulated also in late stages of the disease, suggesting a role in phases in which neurodegeneration is prevalent. +2 more findings

  19. 2006-04-01

    Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study

    ✓ Peer-reviewed Risk factors Alzheimer disease and associated disorders

    Key finding: The results indicate that vascular factors increase risks for AD and VaD differentially by sex.

  20. 2006-04-01

    Ethnicity, stress, and cortisol function in Hispanic and non-Hispanic white women: A preliminary study of family dementia caregivers and noncaregivers

    ✓ Peer-reviewed Disparities The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: Caregivers had higher levels of 8 am, 5 pm, and 9 pm log cortisol as well as higher perceived stress than noncaregivers. +3 more findings

  21. 2006-04-01

    Improving identification of cognitive impairment in primary care

    ✓ Peer-reviewed Disparities International journal of geriatric psychiatry

    Key finding: A heterogeneous community sample (n=371) of predominantly ethnic minority elderly assessed by standardized research protocol, 231 of whom met criteria for dementia or mild cognitive impairment (MCI). +1 more finding

  22. 2006-04-01

    Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures

    ✓ Peer-reviewed Caregiving The Lancet. Neurology

    Key finding: Although clinical examinations suggest a relatively low risk for ischaemic complications affecting the brain, new magnetic resonance techniques have led to the awareness of much higher numbers of clinically silent ischaemic brain lesions. +4 more findings

  23. 2006-04-01

    Potentially modifiable risk factors for dementia in identical twins

    ✓ Peer-reviewed Prevention and risk Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Potentially modifiable risk factors from early and midlife, with a cumulative detrimental effect on the brain, contribute to risk of dementia. +1 more finding

  24. 2006-04-01

    Mild cognitive impairment

    ✓ Peer-reviewed Prevention and risk Lancet (London, England)

    Key finding: Prevalence in population-based epidemiological studies ranges from 3% to 19% in adults older than 65 years. +4 more findings

  25. 2006-04-01

    [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]

    ✓ Peer-reviewed Treatments Zhonghua nei ke za zhi

    Key finding: As a safe and effective medicine, akatinol memantine, which has a similar effect as donepezil for AD, can remarkably improve the cognition, behavior, and mood of AD patients.

Browse the library by subject, with the full score breakdown →